A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/525 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2679217
The invention provides the use of riboflavin in the manufacture of a medicament for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism. The invention also provides a pharmaceutical product for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism, comprising a pharmaceutically effective amount of an anti-hypertensive agent and riboflavin, and the invention further provides a method of treatment of such a subject comprising the administration of riboflavin.
L'invention porte sur l'utilisation de riboflavine dans la fabrication d'un médicament pour le traitement ou la prophylaxie de l'hypertension chez un sujet homozygote ou hétérozygote pour le polymorphisme MTHFR C677T. L'invention porte également sur un produit pharmaceutique pour le traitement ou la prophylaxie de l'hypertension chez un sujet homozygote ou hétérozygote pour le polymorphisme MTHFR C677T, comprenant une quantité pharmaceutiquement efficace d'un agent hypotenseur et de riboflavine. L'invention porte en outre sur one méthode de traitement d'un tel sujet par administration de riboflavine.
Horigan Geraldine
Mcnulty Helene
Purvis John
Scott John
Strain Sean
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The Provost Fellows And Scholars Of The College Of The Holy And Undivid Ed T
University Of Ulster
Western Health And Social Care Trust
LandOfFree
Use of riboflavin in the treatment of hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of riboflavin in the treatment of hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of riboflavin in the treatment of hypertension will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1407518